Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Recruiting · NCT06280950 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Expanding Liver Transplant Immunosuppression Minimization Via Everolimus | Liver Transplant | Recruiting | Phase 2 | 2026-09-17 | NCT06280950 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor Medical Center (Site #: 71153) | Dallas | United States | 1 |
| Duke University Medical Center (Site #: 71139) | Durham | United States | 2 |
| Houston Methodist (Site #: 71120) | Houston | United States | 1 |
| Icahn School of Medicine at Mount Sinai (Site #: 71115) | New York | United States | 1 |
| Mayo Clinic Hospital Arizona (Site #: 71144) | Phoenix | United States | 1 |
| Northwestern University (Site #: 71110) | Chicago | United States | 1 |
| Ronald Regan at UCLA Medical Center (Site #: 71123) | Los Angeles | United States | 1 |
| University of California, San Diego (Site #: 71179) | San Diego | United States | 1 |
| University of California, San Francisco (Site #: 71108) | San Francisco | United States | 1 |
| University of Michigan (Site #: 71154) | Ann Arbor | United States | 1 |
| University of Pennsylvania (Site #: 71111) | Philadelphia | United States | 2 |
| University of Pittsburgh Medical Center (Site #: 71170) | Pittsburgh | United States | 1 |